- Home
- INM vs ISPC Comparison
INM vs ISPC Comparison
Compare INM & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INM
- ISPC
- Stock Information
- Founded
- INM 1981
- ISPC 2009
- Country
- INM Canada
- ISPC United States
- Employees
- INM N/A
- ISPC N/A
- Industry
- INM Biotechnology: Pharmaceutical Preparations
- ISPC Precision Instruments
- Sector
- INM Health Care
- ISPC Health Care
- Exchange
- INM Nasdaq
- ISPC Nasdaq
- Market Cap
- INM 3.2M
- ISPC 3.2M
- IPO Year
- INM N/A
- ISPC 2021
- Fundamental
- Price
- INM $2.87
- ISPC $1.26
- Analyst Decision
- INM
- ISPC
- Analyst Count
- INM 0
- ISPC 0
- Target Price
- INM N/A
- ISPC N/A
- AVG Volume (30 Days)
- INM 4.1M
- ISPC 37.6K
- Earning Date
- INM 05-12-2025
- ISPC 08-05-2025
- Dividend Yield
- INM N/A
- ISPC N/A
- EPS Growth
- INM N/A
- ISPC N/A
- EPS
- INM N/A
- ISPC N/A
- Revenue
- INM $4,920,990.00
- ISPC $8,058,631.00
- Revenue This Year
- INM N/A
- ISPC $35.93
- Revenue Next Year
- INM N/A
- ISPC N/A
- P/E Ratio
- INM N/A
- ISPC N/A
- Revenue Growth
- INM N/A
- ISPC N/A
- 52 Week Low
- INM $1.72
- ISPC $1.02
- 52 Week High
- INM $15.70
- ISPC $11.80
- Technical
- Relative Strength Index (RSI)
- INM 50.24
- ISPC 55.51
- Support Level
- INM $2.74
- ISPC $1.15
- Resistance Level
- INM $3.45
- ISPC $1.29
- Average True Range (ATR)
- INM 0.70
- ISPC 0.08
- MACD
- INM 0.03
- ISPC 0.02
- Stochastic Oscillator
- INM 9.40
- ISPC 75.00
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.
About ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.